Siglecg Limits the Size of B1a B Cell Lineage by Down-Regulating NFκB Activation

被引:50
作者
Ding, Cheng [1 ,7 ]
Liu, Yan [1 ]
Wang, Yin [1 ]
Park, Bae Keun [6 ]
Wang, Cun-Yu [6 ]
Zheng, Pan [1 ,3 ,4 ,5 ]
Liu, Yang [1 ,2 ,3 ,4 ]
机构
[1] Univ Michigan, Sch Med, Dept Surg, Div Immunotherapy,Sect Gen Surg, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Sch Med, Dept Internal Med, Div Mol Med & Genet, Ann Arbor, MI USA
[3] Univ Michigan, Sch Med, Program Mol Mech Dis, Ann Arbor, MI USA
[4] Univ Michigan, Sch Med, Ctr Comprehens Canc, Ann Arbor, MI USA
[5] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI USA
[6] Univ Calif Los Angeles, Sch Dent, Lab Mol Signaling & Apoptosis, Los Angeles, CA 90024 USA
[7] Ohio State Univ, Integrated Biomed Grad Program, Columbus, OH 43210 USA
来源
PLOS ONE | 2007年 / 2卷 / 10期
基金
美国国家卫生研究院;
关键词
D O I
10.1371/journal.pone.0000997
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background. B1 B cells are believed to be a unique lineage with a distinct developmental pathway, function and activation requirement. How this lineage is genetically determined remained largely obscure. Methods and Principal Findings. Using the Siglecg-deficient mice with a knockin of green-fluorescent protein encoding sequence, we show here that, although the Siglecg gene is broadly expressed at high levels in all stages and/or lineages of B cells tested and at lower levels in other lineages, its deletion selectively expanded the B1a B cell lineages, including the frequency of the B1 cell progenitor in the bone marrow and the number of B1a cells in the peritoneal cavity, by postnatal expansion. The expansion of B1a B cells in the peritoneal correlated with enhanced activation of NF kappa B and was ablated by an IKK inhibitor. Conclusion and Significance. Our data revealed a critical role for Siglec G-NF kappa B pathway in regulating B1a B cell lineage. These data lead to a novel model of B1a lineage development that explains a large array of genetic data in this field.
引用
收藏
页数:10
相关论文
共 27 条
  • [1] Flk-2 is a marker in hematopoietic stem cell differentiation: A simple method to isolate long-term stem cells
    Christensen, JL
    Weissman, IL
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (25) : 14541 - 14546
  • [2] Siglecs and their roles in the immune system
    Crocker, Paul R.
    Paulson, James C.
    Varki, Ajit
    [J]. NATURE REVIEWS IMMUNOLOGY, 2007, 7 (04) : 255 - 266
  • [3] The protean nature of cells in the B lymphocyte lineage
    Hardy, Richard R.
    Kincade, Paul W.
    Dorshkind, Kenneth
    [J]. IMMUNITY, 2007, 26 (06) : 703 - 714
  • [4] MURINE B-CELL DIFFERENTIATION LINEAGES
    HARDY, RR
    HAYAKAWA, K
    PARKS, DR
    HERZENBERG, LA
    HERZENBERG, LA
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1984, 159 (04) : 1169 - 1188
  • [5] A DEVELOPMENTAL SWITCH IN B-LYMPHOPOIESIS
    HARDY, RR
    HAYAKAWA, K
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (24) : 11550 - 11554
  • [6] B cell development pathways
    Hardy, RR
    Hayakawa, K
    [J]. ANNUAL REVIEW OF IMMUNOLOGY, 2001, 19 : 595 - 621
  • [7] Positive selection of anti-Thy-1 autoreactive B-1 cells and natural serum autoantibody production independent from bone marrow B cell development
    Hayakawa, K
    Asano, M
    Shinton, SA
    Gui, M
    Wen, LJ
    Dashoff, J
    Hardy, RR
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 197 (01) : 87 - 99
  • [8] Positive selection of natural autoreactive B cells
    Hayakawa, K
    Asano, M
    Shinton, SA
    Gui, M
    Allman, D
    Stewart, CL
    Silver, J
    Hardy, RR
    [J]. SCIENCE, 1999, 285 (5424) : 113 - 116
  • [9] Siglec-G is a B1 cell-inhibitory receptor that controls expansion and calcium signaling of the B1 cell population
    Hoffmann, Anja
    Kerr, Sheena
    Jellusova, Julia
    Zhang, Jiquan
    Weisel, Florian
    Wellmann, Ute
    Winkler, Thomas H.
    Kneitz, Burkhard
    Crocker, Paul R.
    Nitschke, Lars
    [J]. NATURE IMMUNOLOGY, 2007, 8 (07) : 694 - 704
  • [10] KANTOR AB, 1993, ANNU REV IMMUNOL, V11, P501, DOI 10.1146/annurev.iy.11.040193.002441